Hypofractionated Radiotherapy After Complete Resection for Stage II/III Thymic Epithelial Tumors

Clinical trial NCT07691619 · RECRUITING

Trial details

NCT number: NCT07691619
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Thymic Epithelial Tumor

Start date: 2026-07-14
Primary completion: 2027-06-30
Enrollment: 49

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.